n-acetylserotonin has been researched along with Alzheimer Disease in 1 studies
N-acetylserotonin : An N-acylserotonin resulting from the formal condensation of the primary amino group of serotonin with the carboxy group of acetic acid.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The results obtained warrant the further search for the novel types of safe neuroprotectors among the synthetic NAS/melatonin derivatives." | 1.30 | N-acetylserotonin, melatonin and their derivatives improve cognition and protect against beta-amyloid-induced neurotoxicity. ( Afanasiev, A; Bachurin, S; Beznosko, B; Lermontova, N; Mukhina, T; Oxenkrug, G; Serkova, T; Shevtzova, E; Vankin, G, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachurin, S | 1 |
| Oxenkrug, G | 1 |
| Lermontova, N | 1 |
| Afanasiev, A | 1 |
| Beznosko, B | 1 |
| Vankin, G | 1 |
| Shevtzova, E | 1 |
| Mukhina, T | 1 |
| Serkova, T | 1 |
1 other study available for n-acetylserotonin and Alzheimer Disease
| Article | Year |
|---|---|
N-acetylserotonin, melatonin and their derivatives improve cognition and protect against beta-amyloid-induced neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Avoidance Learning; Aziridines; Cells, Cultured; | 1999 |